| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.019 | 0.9 |